Cargando…
A Higher Cutoff for TSI Would Better Predict Recurrence in Patients With Graves’ Disease?
Introduction: GD is an autoimmune disease mediated by immunoglobulins (Igs) that activate TSH receptor (rTSH). Relapse after withdrawal of antithyroid drugs (ATD) can reach 60%. Measurement of TSH receptor antibodies (TRAb) and thyroid stimulating immunoglobulin (TSI) could be an indirect indicator...
Autores principales: | Fontes, Rosita, Negri, Maurício Massucati, Marui, Suemi, Gomes, Dalva Margareth Valente, Schrank, Yolanda, Castelar Pinheiro, Maria Fernanda Miguens, Fragoso Perozo, Andrea Faria Dutra, Araujo, Paula Bruna Mattos Coelho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089568/ http://dx.doi.org/10.1210/jendso/bvab048.1703 |
Ejemplares similares
-
Evaluation of TRAb and TSI Leves and Thyroid Function in Pregnant Women With Graves’ Disease and Newborn: Preliminary Data
por: Negri, Maurício Massucati, et al.
Publicado: (2021) -
SAT462 TSI Versus TRAb In The Diagnosis Of Grave’s Disease
por: Ibrahim, Katherine, et al.
Publicado: (2023) -
SAT-422 Evaluation of the Siemens Thyroid Stimulating Immunoglobulin (TSI) Assay for Diagnosis and Prognosis of Graves’ Disease
por: Paul, Heather, et al.
Publicado: (2020) -
SAT-415 Clinical Performance of Thyroid-Stimulating Immunoglobulin for Graves′ Disease Diagnosis
por: Marui, Suemi, et al.
Publicado: (2020) -
THU670 Serum TSI Concentration In Patients With Graves’ Disease Undergoing Maintenance-dose Of Antithyroid Drug (ATD) And Its Relationship With Disease Relapse After ATD Withdrawal
por: Nhat Nguyen, Phong Vu, et al.
Publicado: (2023)